<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:107%;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-weight:normal;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:107%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;
	font-weight:normal;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-AU>

<div class=WordSection1>

<h1><span lang=EN-US style='font-size:15.0pt;line-height:107%'>2004B01 Briefly
describe how drugs produce their pharmacological effects. <br>
Illustrate each mechanism with examples.</span></h1>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>List:</span></h3>

<p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Receptor – ion permeability</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Receptor – second messenger</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Receptor – gene transcription</span></p>

<p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Other: physicochemical, enzyme inhibition,
voltage-gated ion channel</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>Receptor -&gt;
↑↓ ion permeability:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Pentameric</span></p>
  </td>
  <td width=500 valign=top style='width:375.05pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>e.g. sevoflurane at GABA-A receptor</span></p>
  <p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Binds receptor beta subunit</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>↑Cl<sup>-</sup> conductance through ionophore</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Hyperpolarisation</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>↓action potential</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Ionotropic glutamate</span></p>
  </td>
  <td width=500 valign=top style='width:375.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>e.g. ketamine at NMDA receptor</span></p>
  <p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Binds PCP site</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>↓Ca<sup>2+</sup>&gt;Na<sup>+</sup>=K<sup>+</sup>
  conductance</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>↓ICF [Ca<sup>2+</sup>] -&gt; ↓action potential</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Ionotropic purinergic</span></p>
  </td>
  <td width=500 valign=top style='width:375.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>e.g. ATP at PX1</span></p>
  <p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Binds receptors</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>↑Na<sup>+</sup> = K<sup>+</sup> &gt; Ca<sup>2+</sup>
  conductance</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>Receptor -&gt;
second messenger:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>G protein-coupled receptor</span></p>
  </td>
  <td width=500 valign=top style='width:375.05pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>e.g. adrenaline agonist at </span><span lang=EN-US>β</span><sub><span
  lang=EN-US>1</span></sub><span lang=EN-US> adrenoceptor, a G<sub>s</sub> GPCR</span></p>
  <p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Binds ECF domain</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Conformational change</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>GTP displaces GDP; </span><span lang=EN-US>α</span><span
  lang=EN-US>-GTP dissociates from </span><span lang=EN-US>β</span><span
  lang=EN-US>γ</span><span lang=EN-US> dimer</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>α</span><span lang=EN-US>-GTP activates
  adenylyl cyclase -&gt; ↑cAMP -&gt; ↑activity PKA -&gt; Phosphorylation of:</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:44.0pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-US>L-Ca<sup>2+</sup>:
  ↑Ca<sup>2+</sup> influx on excitation</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:44.0pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-US>Myosin
  -&gt; ↑rate of cycling</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:44.0pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-US>Troponin
  I and phospholamban-&gt; ↑rate of relaxation</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>*Note G inhibitory (↓cAMP) and Gq (↑IP<sub>3</sub>,
  DAG), others exist</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Receptor tyrosine kinase</span></p>
  </td>
  <td width=500 valign=top style='width:375.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>e.g. insulin agonist at insulin receptor</span></p>
  <p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Binds ECF </span><span lang=EN-US>α</span><span
  lang=EN-US>-subunits</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>ICF </span><span lang=EN-US>β</span><span
  lang=EN-US>-subunits autophosphorylate</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Activation of tyrosine kinase activity</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>↑PI3K activity (e.g. ↑GLUT4 expression)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>↑MAPK activity (growth)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>Receptor -&gt;
↑↓Gene transcription: </span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Transcription factor</span></p>
  </td>
  <td width=500 valign=top style='width:375.05pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>e.g. thyroxine at thyroid hormone receptor</span></p>
  <p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Unbound receptor in cytosol</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Bound receptor migrates to nucleus</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>↑↓gene transcription</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>Other:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Voltage-gated ion channel inhibition</span></p>
  </td>
  <td width=500 valign=top style='width:375.05pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>e.g. lignocaine at VDNaC</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>↓Action potential formation</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Enzyme inhibition</span></p>
  </td>
  <td width=500 valign=top style='width:375.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Reversible: e.g. neostigmine + AChE -&gt;
  carbamylate ester</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Irreversible: e.g. organophosphate + AChE
  -&gt; phosphorylated ester</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Physicochemical</span></p>
  </td>
  <td width=500 valign=top style='width:375.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Alter pH: e.g. sodibic for GORD</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Chelation: e.g. g-cyclodextrin + rocuronium</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Osmosis: lactulose -&gt; stool softening</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:
  .0001pt;text-indent:-32.6pt;line-height:normal'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>?Charge neutralization: heparin (negative) +
  protamine (positive) -&gt; stable salt</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Structural analogy</span></p>
  </td>
  <td width=500 valign=top style='width:375.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-indent:-32.6pt;line-height:normal'><span lang=EN-US style='font-family:
  Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>e.g. azathioprine for purine</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Antibody-antigen</span></p>
  </td>
  <td width=500 valign=top style='width:375.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-indent:-32.6pt;line-height:normal'><span lang=EN-US style='font-family:
  Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>e.g. imatinib for BCR-ABL in chronic myeloid leukaemia</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

</div>

<p class="MsoNormal">Feedback welcome at <a href="mailto:ketaminenightmares@gmail.com">ketaminenightmares@gmail.com</a></p>
</body>

</html>
